Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crown Bioscience Announces Merger with JSR Corporation | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Crown Bioscience Announces Merger with JSR Corporation

The company will become a fully owned subsidiary of JSR Corporation

By: Betsy Louda

, Contract Pharma

Crown Bioscience has announced that they will merge with and become a fully owned subsidiary of the JSR Corporation, headquartered in Tokyo, Japan. The merger, which cost JSR $400 million, produces a fully integrated suite of innovative solutions to support researchers through every stage of drug and diagnostic development – from early research through manufacturing.

The strategic merger integrates Crown Bioscience’s translational technology platform with JSR’s in vitro diagnostic (IVD) solutions, GMP manufacturing capabilities and worldwide distribution networks.  

 

“We are excited to join the JSR family of companies through this innovation-driven strategic partnership,” said Dr. Jean-Pierre Wery, Crown Bioscience’s chief executive officer. “Crown Bioscience’s core competencies in preclinical and translational research combined with JSR’s global footprint, diagnostic solutions and manufacturing capabilities will provide a fully integrated solution to help biopharmaceutical companies get drugs and diagnostics to market more efficiently.”

 

The completion of the merger is expected to close before the end of the second quarter of 2018.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters